Revvity (RVTY) earnings

Earnings (net income) · fiscal 2025
$241.20M

Revvity (RVTY) reported net income of $241.20M in fiscal 2025 (the year ended December 31, 2025). That is 10.8% lower than the $270.39M of fiscal 2024. Figures as of 18 Nov 2026, 03:05 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$241.20M
Change on fiscal 2024
−10.8%
Highest on record
$943.16Mfiscal 2022
Lowest on record
$7.66Mfiscal 2012
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Revvity earnings, in more detail

Across the 18 fiscal years on record (2008–2025), the highest was $943.16M in fiscal 2022 and the lowest $7.66M in fiscal 2012.

History · 18 fiscal years

Earnings (net income) by fiscal year

Revvity earnings, year by year

Revvity (RVTY) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$241.20M 10.8% down
2024$270.39M 61.0% down
2023$693.09M 21.8% up
2022$569.18M—
2022$943.16M 29.6% up
2021$727.89M—
2019$227.56M 4.4% down
2018$237.93M 18.7% down
2017$292.63M—
2017$234.30M 10.3% up
2016$212.43M—
2014$157.78M 5.6% down
2013$167.21M 139.1% up
2012$69.94M—
2012$7.66M 98.0% down
2011$390.98M 376.3% up
2010$82.08M—
2008$126.41M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Revvity and comparable companies
CompanyEarnings (net income)Fiscal year
Medpace Holdings MEDP$451.12M2025
Revvity RVTY$241.20M2025
Exelixis EXEL$782.57M2025
Charles River Laboratories International CRL-$144.34M2025
Neurocrine Biosciences NBIX$478.60M2025
Ascendis Pharma ASND-€228.03M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RVTY

Revvity, figure by figure

Revvity (RVTY) overview: price, valuation and scorecardAll health care companies by market value

Revvity earnings: questions and answers

What is Revvity's net income?

Revvity (RVTY) reported net income of $241.20M in fiscal 2025 (the year ended December 31, 2025). That is 10.8% lower than the $270.39M of fiscal 2024.

What are the highest and lowest net income figures on record for Revvity?

Across the 18 fiscal years on record (2008–2025), the highest was $943.16M in fiscal 2022 and the lowest $7.66M in fiscal 2012.

How is Revvity's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Revvity (RVTY) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/RVTY/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.